MORRISVILLE, North Carolina, April 18, 2016 /PRNewswire/ --
To mark Parkinson's Awareness Month, Worldwide Clinical Trials will host a webinar, titled "Challenges of Clinical Research in Parkinson's Disease," on Wednesday, April 27, 2016 at 11 a.m. ET. Presenting the webinar will be Tom Babic, M.D., Ph.D., vice president of Neuroscience for Worldwide Clinical Trials, who will explore the unique challenges of clinical research in Parkinson's disease, and the opportunities that exist to optimize clinical trial outcomes.
During the 45-minute presentation, Dr. Babic, a board certified neurologist and affiliate professor of clinical neurology, will discuss the prevalence and understanding of Parkinson's disease, looking at disease progression, treatment and drug development strategies. He will highlight efficacy endpoints at various stages of the condition and the role of current clinical treatments. The webinar, which will conclude with a 15-minute question and answer session, also will delve into new concepts affecting the design of clinical trials and key success factors.
"In recognition of Parkinson's Awareness Month, Worldwide Clinical Trials is hosting this interactive discussion about trends and advances, to help sponsors meet their development goals to bring new treatments to the millions of people around the world who are living with this disease," said Dr. Babic. "I look forward to sharing our expertise in this area, and hearing the perspectives of others in this field during the question and answer session."
To register for the Worldwide Clinical Trials webinar, visit: http://go.worldwide.com/2016_Events_Webinar_Parkinsons_Webcast_Registration_LP.
Connect with Worldwide Clinical Trials:
- Tweet: @worldwidetrials marks #Parkinson's Awareness Month with webinar
- Follow us on Twitter: @worldwidetrials
- Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.Worldwide.com.
SOURCE Worldwide Clinical Trials